S

Sana Biotechnology Inc
NASDAQ:SANA

Watchlist Manager
Sana Biotechnology Inc
NASDAQ:SANA
Watchlist
Price: 2.645 USD -0.56%
Market Cap: 588.4m USD
Have any thoughts about
Sana Biotechnology Inc?
Write Note

Intrinsic Value

SANA's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one SANA stock under the Base Case scenario is 0.922 USD. Compared to the current market price of 2.645 USD, Sana Biotechnology Inc is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SANA Intrinsic Value
0.922 USD
Overvaluation 65%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Sana Biotechnology Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SANA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SANA?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Sana Biotechnology Inc

Provide an overview of the primary business activities
of Sana Biotechnology Inc.

What unique competitive advantages
does Sana Biotechnology Inc hold over its rivals?

What risks and challenges
does Sana Biotechnology Inc face in the near future?

Has there been any significant insider trading activity
in Sana Biotechnology Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sana Biotechnology Inc.

Provide P/S
for Sana Biotechnology Inc.

Provide P/E
for Sana Biotechnology Inc.

Provide P/OCF
for Sana Biotechnology Inc.

Provide P/FCFE
for Sana Biotechnology Inc.

Provide P/B
for Sana Biotechnology Inc.

Provide EV/S
for Sana Biotechnology Inc.

Provide EV/GP
for Sana Biotechnology Inc.

Provide EV/EBITDA
for Sana Biotechnology Inc.

Provide EV/EBIT
for Sana Biotechnology Inc.

Provide EV/OCF
for Sana Biotechnology Inc.

Provide EV/FCFF
for Sana Biotechnology Inc.

Provide EV/IC
for Sana Biotechnology Inc.

Show me price targets
for Sana Biotechnology Inc made by professional analysts.

What are the Revenue projections
for Sana Biotechnology Inc?

How accurate were the past Revenue estimates
for Sana Biotechnology Inc?

What are the Net Income projections
for Sana Biotechnology Inc?

How accurate were the past Net Income estimates
for Sana Biotechnology Inc?

What are the EPS projections
for Sana Biotechnology Inc?

How accurate were the past EPS estimates
for Sana Biotechnology Inc?

What are the EBIT projections
for Sana Biotechnology Inc?

How accurate were the past EBIT estimates
for Sana Biotechnology Inc?

Compare the revenue forecasts
for Sana Biotechnology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sana Biotechnology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sana Biotechnology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sana Biotechnology Inc compared to its peers.

Compare the P/E ratios
of Sana Biotechnology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sana Biotechnology Inc with its peers.

Analyze the financial leverage
of Sana Biotechnology Inc compared to its main competitors.

Show all profitability ratios
for Sana Biotechnology Inc.

Provide ROE
for Sana Biotechnology Inc.

Provide ROA
for Sana Biotechnology Inc.

Provide ROIC
for Sana Biotechnology Inc.

Provide ROCE
for Sana Biotechnology Inc.

Provide Gross Margin
for Sana Biotechnology Inc.

Provide Operating Margin
for Sana Biotechnology Inc.

Provide Net Margin
for Sana Biotechnology Inc.

Provide FCF Margin
for Sana Biotechnology Inc.

Show all solvency ratios
for Sana Biotechnology Inc.

Provide D/E Ratio
for Sana Biotechnology Inc.

Provide D/A Ratio
for Sana Biotechnology Inc.

Provide Interest Coverage Ratio
for Sana Biotechnology Inc.

Provide Altman Z-Score Ratio
for Sana Biotechnology Inc.

Provide Quick Ratio
for Sana Biotechnology Inc.

Provide Current Ratio
for Sana Biotechnology Inc.

Provide Cash Ratio
for Sana Biotechnology Inc.

What is the historical Revenue growth
over the last 5 years for Sana Biotechnology Inc?

What is the historical Net Income growth
over the last 5 years for Sana Biotechnology Inc?

What is the current Free Cash Flow
of Sana Biotechnology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sana Biotechnology Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sana Biotechnology Inc

Current Assets 263.5m
Cash & Short-Term Investments 251.6m
Other Current Assets 11.8m
Non-Current Assets 355.2m
PP&E 149.1m
Intangibles 199.8m
Other Non-Current Assets 6.3m
Current Liabilities 50.7m
Accounts Payable 3.8m
Accrued Liabilities 44.8m
Other Current Liabilities 2.1m
Non-Current Liabilities 228.3m
Other Non-Current Liabilities 228.3m
Efficiency

Earnings Waterfall
Sana Biotechnology Inc

Revenue
0 USD
Operating Expenses
-252.9m USD
Operating Income
-252.9m USD
Other Expenses
8m USD
Net Income
-244.9m USD

Free Cash Flow Analysis
Sana Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SANA Profitability Score
Profitability Due Diligence

Sana Biotechnology Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Sana Biotechnology Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

SANA Solvency Score
Solvency Due Diligence

Sana Biotechnology Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Sana Biotechnology Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SANA Price Targets Summary
Sana Biotechnology Inc

Wall Street analysts forecast SANA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SANA is 13.668 USD with a low forecast of 11.11 USD and a high forecast of 15.75 USD.

Lowest
Price Target
11.11 USD
320% Upside
Average
Price Target
13.668 USD
417% Upside
Highest
Price Target
15.75 USD
495% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SANA?

Click here to dive deeper.

Dividends

Sana Biotechnology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SANA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SANA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Sana Biotechnology Inc

Country

United States of America

Industry

Biotechnology

Market Cap

594.4m USD

Dividend Yield

0%

Description

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. The company is headquartered in Seattle, Washington and currently employs 383 full-time employees. The company went IPO on 2021-02-04. The firm is focused on creating and delivering engineered cells as medicines for patients. The firm develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing and controlling genes in the body, referred to as gene therapy or in vivo cell engineering, requires in vivo delivery of a therapeutic payload and modification of the genome. The Company’s fusogen technology in preclinical studies targets cell surface receptors when combined with delivery vehicles to form fusosomes and allows cell-specific delivery across multiple different cell types. The company focuses this technology on delivering payloads to T cells, hepatocytes, and hematopoietic stem cells (HSCs).

Contact

WASHINGTON
Seattle
188 East Blaine Street, Suit 400, Suite 400
+12067017914.0
sana.com

IPO

2021-02-04

Employees

383

Officers

President, CEO & Director
Dr. Steven D. Harr M.D.
Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting
Ms. Susan Wyrick
Senior VP & Chief Technical Officer
Mr. Snehal Patel
Executive VP & Chief Scientific Officer
Dr. Dhavalkumar D. Patel M.D., Ph.D.
Executive VP, General Counsel & Corporate Secretary
Mr. Bernard J. Cassidy J.D.

See Also

Discover More
What is the Intrinsic Value of one SANA stock?

The intrinsic value of one SANA stock under the Base Case scenario is 0.922 USD.

Is SANA stock undervalued or overvalued?

Compared to the current market price of 2.645 USD, Sana Biotechnology Inc is Overvalued by 65%.

Back to Top